Data as of Dec 19
| -0.05 / -1.94%|
The 5 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 4.30 and a low estimate of 1.50. The median estimate represents a +18.58% increase from the last price of 2.53.
The current consensus among 7 polled investment analysts is to Buy stock in Sunesis Pharmaceuticals Inc. This rating has held steady since December, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.